Navigation Links
Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xi'an Qinba Xintong Medical Ltd.
Date:9/5/2008

unded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. http://www.hfgb.cn/

This press release may contain forward-looking statements. These statements are based on the current expectations or beliefs of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward- looking statements, including but not limited to the fluctuation of prices of raw materials, the market demand for our products, changes in governmental regulations and/or economic policies and our ability to penetrate new markets.

For more information, please contact:

Dan Carlson, Primary Capital LLC

Email: DCarlson@PrimaryLLC.com

Kelly Black, CEO Premier Media Services, Inc.

Tel: +1-480-649-8224

Email: kblack@premiermediaserice.com


'/>"/>
SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
2. Huifeng Bio-Pharmaceutical (HFGB) to Release First Quarter 2008 Earnings Results on May 15, 2008
3. Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities
4. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on Current Business and COS Certification
5. Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poors Market Access Program
6. Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
7. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status
8. Huifeng Bio-Pharmaceutical (HFGB) to Release Second Quarter 2008 Earnings Results on August 15, 2008
9. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
10. Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008
11. Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Atlanta, GA (PRWEB) May 17, 2013 ... Obstetrics, Gynecology, and Women’s Health at the Albert Einstein ... of Oncology at the Montefiore Medical Center. He ... Einstein Cancer Center and leads the Einstein Breast Cancer ... focused on translational breast cancer research. He also serves ...
(Date:5/17/2013)... transplant recipient,s immune system identifies the transplanted organ as ... that T cells, the immune cells that mediate rejection, ... in order to migrate to the transplanted organ. In ... , Fadi Lakkis and colleagues at the University of ... T cells is not required for migration. Instead, these ...
(Date:5/17/2013)... world-leading provider of scientific, technical and medical information products ... study in Reproductive BioMedicine Online ... an abnormal chromosomal composition can be identified by the ... classifying the risk of genetic abnormality without a biopsy. ... a retrospective study, using their predictive model to assess ...
(Date:5/17/2013)... 17, 2013 •    First of its kind ... sustainability ,     New facility will help solve crop ... Syngenta unveiled its new crop research facility ... RTP Innovation Center. The first of its kind, $72 ... any agricultural climate and precisely measure plant inputs – ...
Breaking Biology Technology:Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3
... & Conference Held in Pittsburgh - Over 1,000 Expected ... Attendees to Discuss New Technologies, New Business, PITTSBURGH, ... forum for the growing business of using,waste materials and ... will take place in downtown Pittsburgh,s David L. Lawrence,Convention ...
... Speaker at AdvaMed 2008 - Book signing to ... Healthcare policy,regulatory environment, elements of the global marketplace, ... 2008 MedTech Conference., Wednesday panel presentations will ... the wireless & IT sectors, remote patient monitoring,technologies, ...
... Researchers at The University of Texas at San Antonio (UTSA) ... of Texas Health Science Center at San Antonio (UTHSCSA) have ... controlling the early infectious process against Francisella tularensis, ... of tularemia. The findings will be released this week in ...
Cached Biology Technology:Former Speaker of the House Newt Gingrich Featured Wednesday 2UTSA/UTHSCSA publish results on bio-threat agent 2
(Date:5/16/2013)... (GWA), where the entirety of an individual,s DNA is ... which can cause health problems is a massively useful ... pose major ethical problems if used incorrectly, say new ... published on line today (16 May 2013) in the ... based on whole genome and on exome* sequencing and ...
(Date:5/16/2013)... 2013 Reportlinker.com announces that a ... its catalogue: Global Biometric ... http://www.reportlinker.com/p01181929/Global-Biometric-Systems-Market-Forecast--Opportunities-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems Lack ... such as photographs, passwords and PIN codes ... in last few years. Security threats such ...
(Date:5/15/2013)... trial to date to examine the efficacy of PARP ... than breast and ovarian cancer, the oral drug olaparib ... prostate cancers. Results of the study, led by researchers ... of Pennsylvania and Sheba Medical Center in Tel Hashomer, ... Clinical Oncology,s annual meeting in Chicago in early June ...
Breaking Biology News(10 mins):European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations 2
... was originally believed to be involved in tuberculosis antibiotic ... pathway for an agent used by the bacteria to ... of the Week" in the April 8 issue of ... Biochemistry and Molecular Biology journal. , Mycobacterium tuberculosis, the ...
... be brought to the marketplace, giving laboratories everywhere ... Transfer GmbH (EMBLEM), the commercial entity of the ... it has signed a licensing deal with technological ... called SPIM (Selective Plane Illumination Microscopy). , "Microscopes ...
... very special mice, scientists have discovered a new tumor ... the development of human leukemia, findings that open up ... say. , Researchers in The Ohio State University Comprehensive ... acute lymphoblastic leukemia (ALL). The mouse first goes through ...
Cached Biology News:Scientists find missing enzyme for tuberculosis iron scavenging pathway 2The transparent organism: EMBLEM and Carl Zeiss give labs a unique look at life 2Genome-wide mouse study yields link to human leukemia 2Genome-wide mouse study yields link to human leukemia 3
Goat polyclonal to NIR1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SWARGPPKFESVP, corresponding to C terminal amino acids 962-974 of NIR1. Entrez Gene ID: 83394 ...
HOXC11 Antibody...
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Biology Products: